Eldelumab
Eldelumab Uses, Dosage, Side Effects, Food Interaction and all others data.
MDX-1100, a fully human antibody that targets IP10 (also known as CXCL10), a chemokine expressed in association with multiple inflammatory disease indications, such as rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis.
Trade Name | Eldelumab |
Generic | Eldelumab |
Eldelumab Other Names | Eldelumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in ulcerative colitis.
How Eldelumab works
MDX-1100 binds selectively to CXCL10 and blocks CXCL10 induced calcium flux and cell migration.
Innovators Monograph
You find simplified version here Eldelumab